Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

CB2 receptor agonist proves useful for the treatment of erectile dysfunction

Sep. 3, 2012

Takeda presents novel inhibitors of ACC2

Sep. 3, 2012

Topical cream improves female sexual arousal disorder in phase III trial

Aug. 31, 2012

Noven files NDA for therapy for menopausal vasomotor symptoms

Aug. 30, 2012

FDA provides recommendations for Proellex trial

Aug. 28, 2012

Tenelia set for launch in Japan

Aug. 28, 2012

Recruitment begins for phase III trial in children with precocious puberty

Aug. 28, 2012

Growject approved for fourth indication in Japan

Aug. 24, 2012

Sato Pharmaceutical designs new urate anion exchanger inhibitors

Aug. 24, 2012

Investigators extract new HMG-CoA reductase inhibitors from yeast

Aug. 24, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...